RNA / Research / Pharmaceutical / RNAi / Drug / Pharmaceuticals / Drugs / Therapeutics / National blog main / Wisconsin / Wisconsin blog main / Wisconsin top stories / Alnylam Pharmaceuticals / Alpha-1 antitrypsin / Amgen / Arrowhead Pharmaceuticals / Chris Anzalone / David Lewis / EX1 / gene-silencing / Life Sciences / patisiran / RNA Interference / trim platform

Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool

Posted on: Sep 19, 2017   |   Posted by: Biotech Mag Top

Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool

Following a series of setbacks late last year, Arrowhead Pharmaceuticals, one of the companies trying to develop drugs using RNA interference, has come up with a plan to try to...

Continue reading ...